Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02383628 · ClinicalTrials.gov registry record
Endoscopic Perfusion Utilizing ICG Fluorescence Technology
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 197
- Enrollment target
NCT02383628: Completed study, sponsored by University of Pittsburgh.
NCT02383628 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 197 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02383628 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 197 participants
- Enrollment target
Study Summary
The main objective of the study is to evaluate the efficacy of indocyanine green (ICG) endoscopy to evaluate tissue perfusion during endoscopic neurosurgery. This includes patients with pituitary and intracranial tumors and treatment of vascular abnormalities such as aneurysms and compressive syndromes. ICG will be evaluated to determine the value of the additional visual information supplied during the treatment of these pathologies.
Primary Outcome
compare efficacy of tissue perfusion with and without ICG Dye and light filter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2015-10 |
| Est. Completion | 2018-06 |
What the finished NCT02383628 record still lists
NCT02383628 is an observational study that tracks outcomes without assigning an intervention. The registered 197 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02383628 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02383628 about?
NCT02383628 is a clinical study titled "Endoscopic Perfusion Utilizing ICG Fluorescence Technology". The main objective of the study is to evaluate the efficacy of indocyanine green (ICG) endoscopy to evaluate tissue perfusion during endoscopic neurosurgery. This includes patients with pituitary and intracranial tumors and treatment of vascular abnormalities such as aneurysms and compressive syndro...
What is the current status of trial NCT02383628?
This trial is currently completed. The enrollment target is 197 participants. The study started on 2015-10. Estimated completion is 2018-06.
Who is sponsoring clinical trial NCT02383628?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04219254 · 197 participants · Phase 1
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- NCT06173778 · 197 participants · Phase 2
Semaglutide for Post-Smoking Cessation Weight Management
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia